Canada Markets open in 21 mins

Genmab A/S (GMAB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
44.04-0.22 (-0.50%)
At close: 4:00PM EDT
Sign in to post a message.
  • a
    BAL will get approved.

    The approval of the following From loncar:

    Lately the news has been ADC palooza. $SGEN & $GMAB were just approved in cervical cancer.
  • M
    Why is it falling right now though? I can't see any bad press or anything (will be buying the dip ofc)
  • H
    We will see 100 this year!
    Takeover rumours are increased
  • L
    Down 4% extended hours, please keep staying low so I can buy more
  • P
    Anyone know why the recent increase sp?
  • S
    Stocks Technical
    Hoping for this GMAB bounce intraday. Nice mention alongside a few cancer stocks today so I'm happy so far
  • B
    My target price is 57 to 65 dollars in the short term. In the long term, the growth could be exponential.
  • K
    Even Pipeline expanding. genmab is like a mutual find of biotech with over 20 candidates over 33 different indications
  • J
    It look be just a matter of time until someone takes this company out. Great pipeline/no debt and plenty of cash on hand. Just hold and wait.
  • J
    Looks like things are starting are starting to heat up. Horizon report on may 5th be interesting and seeing how the Tepezza sales are going. I have a feeling in 2 years this stock price will double as there is a lot coming down the pipeline just my gut from what I have been reading
  • D
    Great pipeline and Darzalex Fast Pro off to a good start even during Covid. Can’t get a better pipeline and already in the black for a young US company- IPO wasn’t that long ago! Long and strong/ forget that sell side today!! Want to get the shares cheaper as the analysts wake up to a great company!!
  • B
    Free Cash Flow increasing from 1.2 billions to over 6 billions DKK. That is almost 600% jump with further growth and recurring revenue ! This is a super growth stock. Stock price will jump.
  • K
    When JNJ took out Actelion for $30 billion it had no earnings and paid $280 a share. Genmab has $250 million USD net income already and is valued at only 6 billion.Putting same price on Genmab would be $500
  • I
    What is this ...GMAB gets FDA approval on an MS drug and no market reaction??? I just bought some... hoping for markets react positively....
  • M
    Copenhagen, Denmark; January 15, 2021 – Genmab A/S (Nasdaq: GMAB) announced today that the U.S. Food and Drug Administration (U.S. FDA) has approved the use of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide, and dexamethasone (VCd) for the treatment of adult patients with newly diagnosed light-chain (AL) amyloidosis.
  • K
    I listened to conference. Newest Darzulex indication just approved by FDA yesterday could double royalty income from JNJ in coming year
  • K
    $SRPT conversation
    Highlights from RBC 2020 #biotech outlook

  • L
    $AGEN conversation
    Stolen from the twitterverse:

    Genmab $GMAB Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer

    $GMAB was targeting 20-ish % and min DOR 6mo so targets met with 24% and 8.3mo.
  • W
    dont know why this didnt move on the abbvie news.
  • K
    Split shares because management feels undervalued